Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

19.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
19.4K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

7.3K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

5.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.6K
1.6K
Mitochondria01:37

Mitochondria

21.1K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
21.1K
Mitochondrial Membranes01:45

Mitochondrial Membranes

17.6K
A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
17.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeting competitive Fe-S regulation to treat Friedreich's ataxia.

Trends in pharmacological sciences·2026
Same author

The impact of muscle inactivity and exercise training on histidine-dipeptide homeostasis in rat skeletal muscle.

American journal of physiology. Regulatory, integrative and comparative physiology·2026
Same author

Targeting ALDH2 to promote skeletal muscle health: A novel strategy against mitochondrial dysfunction.

The Journal of physiology·2025
Same author

A coculture model to study sympathetic regulation of the maturation of human pluripotent stem cell-derived cardiomyocytes.

The Journal of physiology·2025
Same author

Corrigendum: Novel and prevalent non-East Asian ALDH2 variants; implications for global susceptibility to aldehydes' toxicity EBioMedicine (2020) - doi: 10.1016/j.ebiom.2020.102753.

EBioMedicine·2025
Same author

Tic-tac-mito: The relationship between the biological clock with mitochondria dynamics and skeletal muscle function in humans.

The Journal of physiology·2024
Same journal

Hyocholic acids: Third bile acids for neonatal health.

Trends in molecular medicine·2026
Same journal

Clonal hematopoiesis in Alzheimer's brain: Protective, pathogenic, and context-dependent?

Trends in molecular medicine·2026
Same journal

Targeting amino acid metabolism in hepatocellular carcinoma.

Trends in molecular medicine·2026
Same journal

Turning perfusion into repair through ferroptosis blockade.

Trends in molecular medicine·2026
Same journal

CaMKK2: A tumor stress-integration node.

Trends in molecular medicine·2026
Same journal

Precision gene editing: From proof-of-concept to curative therapies.

Trends in molecular medicine·2026
See all related articles

Related Experiment Video

Updated: Mar 15, 2026

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
08:55

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

Published on: November 30, 2016

17.3K

cAMP and mitochondrial dysfunction in cancer cachexia.

Itamar C G Jesus1, Julio C B Ferreira1

  • 1Department of Anatomy, Institute of Biomedical Sciences, University of Sao Paulo, São Paulo, Brazil.

Trends in Molecular Medicine
|March 13, 2026
PubMed
Summary
This summary is machine-generated.

Cancer cachexia impairs musculoskeletal signaling, causing mitochondrial dysfunction. Researchers identified a key pathway and demonstrated that a phosphodiesterase-4 inhibitor can restore function, offering a potential therapeutic approach.

Keywords:
PDE4DcAMPcancer cachexiamitochondrial dysfunction

More Related Videos

Evaluating the Role of Mitochondrial Function in Cancer-related Fatigue
08:56

Evaluating the Role of Mitochondrial Function in Cancer-related Fatigue

Published on: May 17, 2018

9.7K
Author Spotlight: Unveiling Mitochondrial Function and Cellular Metabolic Adaptation in Metabolic Diseases
08:12

Author Spotlight: Unveiling Mitochondrial Function and Cellular Metabolic Adaptation in Metabolic Diseases

Published on: October 4, 2024

2.4K

Related Experiment Videos

Last Updated: Mar 15, 2026

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
08:55

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

Published on: November 30, 2016

17.3K
Evaluating the Role of Mitochondrial Function in Cancer-related Fatigue
08:56

Evaluating the Role of Mitochondrial Function in Cancer-related Fatigue

Published on: May 17, 2018

9.7K
Author Spotlight: Unveiling Mitochondrial Function and Cellular Metabolic Adaptation in Metabolic Diseases
08:12

Author Spotlight: Unveiling Mitochondrial Function and Cellular Metabolic Adaptation in Metabolic Diseases

Published on: October 4, 2024

2.4K

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Cancer cachexia is a debilitating condition characterized by progressive muscle wasting and metabolic disturbances.
  • Mitochondrial dysfunction is a key contributor to the pathophysiology of cancer cachexia, impacting cellular energy production and muscle function.

Purpose of the Study:

  • To investigate the intracellular signaling pathways implicated in musculoskeletal mitochondrial dysfunction in cancer cachexia.
  • To identify potential therapeutic targets for mitigating cancer cachexia-associated muscle wasting and dysfunction.

Main Methods:

  • Analysis of the 3',5'-cyclic adenosine monophosphate (cAMP)-protein kinase A-cAMP response element-binding protein 1 signaling pathway in muscle tissue from humans and mice with cancer cachexia.
  • Assessment of mitochondrial function in response to pathway modulation.
  • Treatment with a phosphodiesterase-4 inhibitor to rescue the identified signaling defect.

Main Results:

  • Cancer cachexia in both humans and mice is associated with impaired cAMP-PKA-CREB1 signaling in skeletal muscle.
  • This signaling deficit directly contributes to mitochondrial dysfunction.
  • Pharmacological intervention with a phosphodiesterase-4 inhibitor successfully restored the impaired signaling pathway and improved mitochondrial function.

Conclusions:

  • The cAMP-PKA-CREB1 pathway is a critical mediator of mitochondrial dysfunction in cancer cachexia.
  • Targeting this pathway with phosphodiesterase-4 inhibitors represents a promising therapeutic strategy for managing cancer cachexia and its associated musculoskeletal complications.